NCT04907825View on ClinicalTrials.gov

A Trial of Pharmacist Management of Oral Anticoagulation THerapy Versus Enhanced Usual CARe in the communitY for AF

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Atrial FibrillationStroke
Interventions
DRUG

Oral anticoagulant

Anticoagulant therapy will be initiated/titrated in patients with atrial fibrillation in accordance with ACC/AHA/HRS Guidelines

Trial Locations (1)

90048

RECRUITING

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Cedars-Sinai Medical Center

OTHER